Targeting of non-small cell lung cancer using HMFG1-99mTc monoclonal antibodies. 1993

S Pavlović, and D Jovanović, and G Radosavljević, and N Kozarević, and D Nastić-Mirić, and R Rebić, and V Bosnjáković, and A Epenetos
Nuclear Medicine Institute, University Clinical Centre, Belgrade.

Anti HMFG1 monoclonal antibodies labeled with 99mTc were used for the detection of non-small cell lung cancers and their metastases in 18 patients (12 squamous cell cancers, 2 large cell lung cancers, 1 adenocarcinoma and 3 undifferentiated non-small cell lung cancer). According to performed therapy all patients were divided into three groups: group 1 consisted of 13 patients who had not received chemotherapy or radiotherapy before immunoscintigraphy (IS), group 2 included 3 patients who had undergone IS during external beam radiotherapy, and group 3 (two patients) who had received both chemotherapy and radiotherapy before IS. After antibody administration planar scintigraphy of the head and neck, chest in anterior and posterior projection, anterior abdomen, pelvis, thighs and calves was obtained at 10 minutes, 5 hours and 24 hours. The scans were interpreted semi-quantitatively using T/NT ratio. In the first group IS was found true positive in 5/13 patients (38%), and T/NT ratio ranged from 1.3-1.5. In the second group all three patients were true positive and T/NT ratio ranged from 1.76 to 2.1. In the third group both patients were found false negative. Successful metastases detection was found in 4/13 patients (30%).

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D002289 Carcinoma, Non-Small-Cell Lung A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy. Carcinoma, Non-Small Cell Lung,Non-Small Cell Lung Cancer,Non-Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinoma,Nonsmall Cell Lung Cancer,Carcinoma, Non Small Cell Lung,Carcinomas, Non-Small-Cell Lung,Lung Carcinoma, Non-Small-Cell,Lung Carcinomas, Non-Small-Cell,Non Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor
D013667 Technetium The first artificially produced element and a radioactive fission product of URANIUM. Technetium has the atomic symbol Tc, and atomic number 43. All technetium isotopes are radioactive. Technetium 99m (m Technetium 99m,99m, Technetium
D016719 Radioimmunodetection Use of radiolabeled antibodies for diagnostic imaging of neoplasms. Antitumor antibodies are labeled with diverse radionuclides including iodine-131, iodine-123, indium-111, or technetium-99m and injected into the patient. Images are obtained by a scintillation camera. Immunoscintigraphy, Radiolabeled,Radioimmunoimaging,Radioimmunoscintigraphy,Immunoscintigraphy, Radiolabelled,Radiolabeled Immunoscintigraphy,Radiolabelled Immunoscintigraphy,Immunoscintigraphies, Radiolabeled,Immunoscintigraphies, Radiolabelled,Radioimmunodetections,Radioimmunoimagings,Radioimmunoscintigraphies,Radiolabeled Immunoscintigraphies,Radiolabelled Immunoscintigraphies
D018396 Mucin-1 Carbohydrate antigen elevated in patients with tumors of the breast, ovary, lung, and prostate as well as other disorders. The mucin is expressed normally by most glandular epithelia but shows particularly increased expression in the breast at lactation and in malignancy. It is thus an established serum marker for breast cancer. Antigen CA-15-3,CA-15-3 Antigen,Episialin,Epithelial Membrane Antigen,Epithelial Mucin, Polymorphic,Muc1 Mucin,Polymorphic Epithelial Mucin,Antigens, CD227,CA 15-3 Antigen,CA 15.3 Antigen,CD227 Antigen,Antigen CA 15 3,Antigen, CA 15-3,Antigen, CA 15.3,Antigen, CA-15-3,Antigen, CD227,Antigen, Epithelial Membrane,CA 15 3 Antigen,CA-15-3, Antigen,CD227 Antigens,Membrane Antigen, Epithelial,Mucin 1,Mucin, Muc1,Mucin, Polymorphic Epithelial

Related Publications

S Pavlović, and D Jovanović, and G Radosavljević, and N Kozarević, and D Nastić-Mirić, and R Rebić, and V Bosnjáković, and A Epenetos
April 1988, Cancer research,
S Pavlović, and D Jovanović, and G Radosavljević, and N Kozarević, and D Nastić-Mirić, and R Rebić, and V Bosnjáković, and A Epenetos
June 1988, Shi yan sheng wu xue bao,
S Pavlović, and D Jovanović, and G Radosavljević, and N Kozarević, and D Nastić-Mirić, and R Rebić, and V Bosnjáković, and A Epenetos
January 1993, Acta oncologica (Stockholm, Sweden),
S Pavlović, and D Jovanović, and G Radosavljević, and N Kozarević, and D Nastić-Mirić, and R Rebić, and V Bosnjáković, and A Epenetos
February 2017, International journal of oncology,
S Pavlović, and D Jovanović, and G Radosavljević, and N Kozarević, and D Nastić-Mirić, and R Rebić, and V Bosnjáković, and A Epenetos
July 1983, Journal of immunology (Baltimore, Md. : 1950),
S Pavlović, and D Jovanović, and G Radosavljević, and N Kozarević, and D Nastić-Mirić, and R Rebić, and V Bosnjáković, and A Epenetos
March 2013, Targeted oncology,
S Pavlović, and D Jovanović, and G Radosavljević, and N Kozarević, and D Nastić-Mirić, and R Rebić, and V Bosnjáković, and A Epenetos
October 2011, Critical reviews in oncology/hematology,
S Pavlović, and D Jovanović, and G Radosavljević, and N Kozarević, and D Nastić-Mirić, and R Rebić, and V Bosnjáković, and A Epenetos
September 2009, Journal of B.U.ON. : official journal of the Balkan Union of Oncology,
S Pavlović, and D Jovanović, and G Radosavljević, and N Kozarević, and D Nastić-Mirić, and R Rebić, and V Bosnjáković, and A Epenetos
September 1991, Biulleten' eksperimental'noi biologii i meditsiny,
S Pavlović, and D Jovanović, and G Radosavljević, and N Kozarević, and D Nastić-Mirić, and R Rebić, and V Bosnjáković, and A Epenetos
March 2006, Annals of oncology : official journal of the European Society for Medical Oncology,
Copied contents to your clipboard!